HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blacksmith Brands Aims To Forge A Platform From Undervalued OTC Products

This article was originally published in The Tan Sheet

Executive Summary

Blacksmith Brands CEO and co-founder Peter Mann plans to build a significant OTC platform by acquiring and nurturing well-known brands "suffering from a lack of attention.

You may also be interested in...



Prestige Brands Makes "Seismic Shift" To OTC With Blacksmith Acquisition

On the eve of Blacksmith Brands' one-year anniversary, co-founder and CEO Peter Mann fulfills his promise to cash in on the startup in a $190 million sale to Prestige Brands Holdings, which Mann also helped launch

J&J Quality Issues, Hill Concerns Spill Over To Blacksmith's PediaCare

The impact of McNeil Consumer Healthcare's quality control lapses extends to Blacksmith Brands, which becomes a congressional inquiry target after recalling PediaCare products manufactured at one of the Johnson & Johnson subsidiary's plants

Dutch Firm Vemedia Partners Outside The Box To Thrive During Recession

Unconventional partnerships may help small and mid-sized consumer health care firms survive or even thrive during the recession says Yvan Vindevogel, CEO of Vemedia Pharma, a European consumer health care firm

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel